Table 2

Crude and adjusted ORs and 95% CIs for association between clinical outcomes and serum albumin level

VariablePrevalence (%)Crude OR (95% CI)Adjusted OR (95% CI)
Clinical remission
 Low albumin48/93 (51.6)11
 Moderate albumin60/98 (61.2)1.48 (0.83 to 2.64)1.13 (0.56 to 2.28)
 High albumin50/92 (61)1.46 (0.80 to 2.69)1.41 (0.66 to 3.03)
 p for trend0.38
Partial mucosal healing (MES ≤1)
 Low albumin51/93 (54.8)11
 Moderate albumin67/98 (68.4)1.78 (0.99 to 3.23)1.26 (0.63 to 2.53)
 High albumin54/82 (65.9)1.59 (0.86 to 2.95)1.18 (0.56 to 2.50)
 p for trend0.67
Mucosal healing (MES <1)
 Low albumin18/93 (19.4)11
 Moderate albumin27/98 (27.6)1.59 (0.81 to 3.16)1.56 (0.74 to 3.38)
 High albumin26/82 (31.7)1.94 (1.97 to 3.92)2.29 (1.03 to 5.29)
 p for trend0.043
  • ORs were adjusted for age, sex, body mass index, use of prednisolone, use of tumour necrosis factor-α monoclonal antibody, C reactive protein, disease extent and disease duration.

  • MES, Mayo endoscopic subscore.